Aarey Drugs & Pharmaceuticals Bilan de santé
Santé financière contrôle des critères 3/6
Aarey Drugs & Pharmaceuticals has a total shareholder equity of ₹1.3B and total debt of ₹313.5M, which brings its debt-to-equity ratio to 23.6%. Its total assets and total liabilities are ₹3.0B and ₹1.7B respectively. Aarey Drugs & Pharmaceuticals's EBIT is ₹25.4M making its interest coverage ratio 0.6. It has cash and short-term investments of ₹28.9M.
Informations clés
23.6%
Ratio d'endettement
₹313.52m
Dette
| Ratio de couverture des intérêts | 0.6x |
| Argent liquide | ₹28.90m |
| Fonds propres | ₹1.33b |
| Total du passif | ₹1.71b |
| Total des actifs | ₹3.03b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
Analyse de la situation financière
Passif à court terme: 524412's short term assets (₹2.8B) exceed its short term liabilities (₹1.7B).
Passif à long terme: 524412's short term assets (₹2.8B) exceed its long term liabilities (₹39.7M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 524412's net debt to equity ratio (21.4%) is considered satisfactory.
Réduire la dette: 524412's debt to equity ratio has increased from 18.7% to 23.6% over the past 5 years.
Couverture de la dette: 524412's operating cash flow is negative, therefore debt is not well covered.
Couverture des intérêts: 524412's interest payments on its debt are not well covered by EBIT (0.6x coverage).